<- Back to digest

Spine - 2026-11-15 - Journal Article

Perioperative Aspirin Continuation is Not Associated With Increased Surgical Morbidity Following Minimally Invasive Anterior-to-Psoas Lumbar Fusion: A Propensity-Matched Analysis.

Kim MT, Li M, Khan RR, Dhunna DP, Lee S, Tao BS, El-Hajj N, Abdelnour R, Ryali R, Khan SR, Tannoury T, Tannoury C

retrospective cohortLOE IIIn = 172 (86 propensity-matched pairs from 455 eligible patients)N/A

Topics

spine
PMID: 42773907DOI: 10.1097/BRS.0000000000005878View on PubMed ->

Key Takeaway

Perioperative low-dose aspirin continuation in MIS-ATP lumbar fusion did not increase EBL (244 vs 278 mL), transfusion rate (18.6% vs 15.1%), or retroperitoneal hematoma rate (1.2% vs 1.2%) compared to discontinuation in 86 propensity-matched pairs.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study asked whether continuing low-dose aspirin perioperatively increases surgical morbidity in MIS-ATP lumbar fusion with supplemental percutaneous posterior fixation. Using 1:1 propensity score matching across 455 patients at a single academic center (2014–2020), 86 aspirin-continuation patients were matched to 86 discontinuation patients. No significant differences were found in operative time, EBL, day-1 hemoglobin, LOS, transfusion rate, or retroperitoneal hematoma; a subanalysis of ≥7-day preoperative hold (15 matched pairs) showed no additional benefit from prolonged discontinuation.

Key Limitation

Single-center retrospective design with only 86 matched pairs limits generalizability and statistical power to detect low-frequency complications such as retroperitoneal hematoma, where even a doubling of rate would be undetectable at this sample size.

Original Abstract

STUDY DESIGN

Retrospective cohort study with propensity score matching.

OBJECTIVE

To evaluate the impact of perioperative aspirin continuation on surgical and postoperative outcomes following minimally invasive anterior-to-psoas (MIS-ATP) lumbar fusion.

SUMMARY OF BACKGROUND DATA

Perioperative aspirin management in spine surgery remains controversial, with concerns centered on bleeding risk versus thrombotic complications associated with discontinuation. Evidence specific to minimally invasive lumbar fusion techniques, particularly the MIS-ATP approach, is limited.

MATERIALS AND METHODS

Adult patients who underwent MIS-ATP lumbar fusion with supplemental posterior percutaneous fixation at a single academic medical center (2014-2020) were included. Patients who continued low-dose aspirin through the perioperative period were compared with those who discontinued aspirin preoperatively. Propensity score matching (1:1 nearest-neighbor) incorporated age, sex, BMI, race/ethnicity, fusion levels, comorbidities (hypertension, diabetes mellitus, CAD, COPD, and CKD), smoking, alcohol use, and preoperative laboratory values. Primary outcomes included operative time, estimated blood loss (EBL), postoperative day-1 hemoglobin, and length of stay. A subanalysis compared aspirin continuers with patients who held aspirin ≥7 days preoperatively.

RESULTS

Of 455 eligible patients, 134 (29.5%) continued aspirin and 321 (70.5%) discontinued. Propensity matching yielded 86 well-balanced pairs (n=172). Operative time (224.7±97.9 vs . 228.6±90.1 min; P =0.79), EBL (244.4±456.0 vs . 278.4±418.7 mL; P =0.62), postoperative day-1 hemoglobin (10.88±1.49 vs . 11.08±1.76 g/dL; P =0.41), and length of stay (4.83±3.72 vs . 4.20±2.49 d; P =0.22) did not differ significantly. Transfusion rates (18.6% vs . 15.1%; P =0.54) and retroperitoneal hematoma (1.2% vs . 1.2%; P =1.00) were comparable. The ≥7-day-hold subanalysis (15 matched pairs) showed no outcome advantage over continuation.

CONCLUSION

Perioperative continuation of low-dose aspirin in appropriately selected patients undergoing MIS-ATP lumbar fusion was not associated with increased surgical morbidity or postoperative complications, supporting an individualized, approach-specific approach to perioperative antiplatelet management.